Explore
Validate
LearnABIN2840602
antibody from antibodies-online
Targeting: LPAR1
edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2840602 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-BUD31 Homolog (Yeast) (BUD31) (AA 21-50), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 21-50, N-Term
- Antibody clone number
- RB01825
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.
Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.
Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Clézardin P, Peyruchaud O
Proceedings of the National Academy of Sciences of the United States of America 2006 Jun 20;103(25):9643-8
Proceedings of the National Academy of Sciences of the United States of America 2006 Jun 20;103(25):9643-8
Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.
Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H, Sugano S
Oncogene 2003 May 22;22(21):3307-18
Oncogene 2003 May 22;22(21):3307-18
Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.
Van Leeuwen FN, Olivo C, Grivell S, Giepmans BN, Collard JG, Moolenaar WH
The Journal of biological chemistry 2003 Jan 3;278(1):400-6
The Journal of biological chemistry 2003 Jan 3;278(1):400-6
Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y, Nagawa H
Cancer research 2003 Apr 1;63(7):1706-11
Cancer research 2003 Apr 1;63(7):1706-11
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
